BioTime (BTX) Tops Q2 EPS by 5c

BioTime (NYSE: BTX) reported Q2 EPS of ($0.03), $0.05 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $557 thousand.

For earnings history and earnings-related data on BioTime (BTX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Academy Sports and Outdoor (ASO) Misses Q1 EPS by 1c ; Offers Guidance
• Oxford Industries (OXM) Tops Q1 EPS by 12c; Offers Outlook